West Pharmaceutical Services | WST - Ativo Circulante





Ativo Circulante Alterar Data
Align Technology USD 2.66B 38.87M 2026-03
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Cerus USD 174.38M 7.26M 2025-12
Charles River Laboratories USD 1.49B 41.76M 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dentsply International USD 1.85B 178M 2026-03
Haemonetics USD 834.88M 108.8M 2026-03
ICU Medical USD 1.21B 22.69M 2026-03
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.1B 61.62M 2026-03
Neogen USD 590M 15.42M 2025-12
OraSure Technologies USD 240.78M 21.13M 2026-03
Quidel USD 1.38B 70.3M 2026-03
Repligen USD 1.16B 23.98M 2026-03
Rockwell Medical USD 31.61M 1.42M 2025-06
Solventum Corp USD 3.58B 276M 2026-03
STAAR Surgical USD 312.4M 853K 2026-03
Terumo JPY 861.04B 45.48B 2026-03
Utah Medical Products USD 97.74M 1.21M 2025-12
West Pharmaceutical Services USD 1.83B 151.4M 2026-03